Evidence map›Paper›PMID 25589803›Full record

ArticleIndian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India

Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy.

Sellam Karunanithi, Ganesh Kumar, Punit Sharma, Chandrasekhar Bal, Rakesh Kumar

Abstract read
In one paragraph

Article in Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sellam KarunanithiDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Ganesh KumarDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Punit SharmaDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Chandrasekhar BalDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Rakesh KumarDepartment of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generalized lymphadenopathy is a common and often vexing clinical problem caused by various inflammatory, infective and malignant diseases. We aimed to review briefly and highlight the potential role of (18)F-2-fluoro-2-deoxy-glucose ((18)F-FDG) positron emission tomography/computed tomography (PET/CT) in such patients. (18)F-FDG PET/CT can play an important role in the management of generalized lymphadenopathy. It can help in making an etiological diagnosis; can detect extranodal sites of involvement and employed for monitoring response to therapy.

Indexed as

18F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomographygeneralized lymphadenopathylymphomasarcoidosistuberculosis

Identifiers

PMID25589803
PMCPMC4290063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.